Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 17
Nanoscale
How to view nanomaterials
TO VIEW EXTREMELY SMALL NANOMATERIALS, SCIENTISTS USE SPECIAL MICROSCOPES. IN THE 1930S, THEY USED ELECTRON AND FIELD MICROSCOPES. TODAY, THERE ARE ADVANCED MICROSCOPES LIKE THE SCANNING TUNNELING MICROSCOPE AND ATOMIC FORCE MICROSCOPE THAT ALLOW US TO SEE NANOMATERIALS IN GREAT DETAIL. 1.) Electron microscope the electron microscope, invented by German engineers Ernst Ruska and Max Knoll in the 1930s, uses a beam of electrons to illuminate a specimen and produce highly magnified images. Electron microscopes have higher resolution and can magnify objects up to a million times, compared to conventional light microscopes that can only magnify objects up to 1500 times. There are two general types of electron microscopes: scanning electron microscope (SEM) and transmission electron microscope (TEM). 2.) Atomic force microscope
The atomic force microscope (AFM)
was developed in 1986 by Gerd Binig, Calvin Quate, and Christoph Gerber. It uses a mechanical probe to collect information from the surface of a material. 3.) Scanning tunneling microscope ⁸ You the scanning tunneling microscope (STM) allows scientists to observe and manipulate nanoscale particles, atoms, and small molecules. In 1986, Gerd Binig and Heinrich Rohrer were awarded the Nobel Prize in Physics for their contributions to the invention of the scanning tunneling microscope. CHAPTER 10: THE ASPECTS OF GENE THERAPY The process of gene therapy The basic process involves various approaches, as outlined by Fliester in 2017. These approaches include replacing a mutated gene causing a disease with a healthy copy, inactivating a malfunctioning gene, and introducing a new gene to combat a specific illness. Gene therapy aims to address diseases at their core by correcting abnormal genes associated with specific conditions. Two types of There are two main forms of gene therapy:
gene therapy somatic gene therapy
germ-line gene therapy. Somatic gene therapy focuses on manipulating genes in cells that benefit the patient without being passed on to future generations. In contrast, germ-line gene therapy involves genetic modifications of germ cells or origin cells that can transmit the changes to the next generation. These distinct approaches offer targeted solutions for treating genetic disorders while considering implications for heredity and future generations. Somatic gene therapy focuses on manipulating genes in cells that benefit the patient without being passed on to future generations. In contrast, germ-line gene therapy involves genetic modifications of germ cells or origin cells that can transmit the changes to the next generation. These distinct approaches offer targeted solutions for treating genetic disorders while considering implications for heredity and future generations. Stem cells are versatile cells with the potential to develop into various cell types in the body. They can self-renew and differentiate into cells of the blood, heart, bones, skin, muscles, brain, and more. Stem cells can be derived from different sources, STEM CELL including embryonic stem cells from early human embryos and somatic stem cells found in various GENE tissues throughout the body. Somatic stem cells can remain dormant for extended periods until activated THERAPY by disease or injury, after which they can divide and generate different cell types. While somatic stem cells were initially believed to have limited differentiation capabilities, there is some evidence suggesting they can develop into other cell types as well. Stem cells are derived from different sources. Two of which are embryonic and somatic stem cells. The bioethics of Gene therapy Gene therapy raises significant ethical concerns, including the distinction between beneficial and harmful applications, the determination of what traits are considered normal versus disabilities, and the potential exclusivity of gene therapy due to high costs. Additionally, there are worries that widespread gene therapy usage could lead to societal discrimination against those who are different. The debate extends to germline therapy, which involves modifying germ cells to pass genetic changes to future generations, raising questions about the impact on unborn children and future generations. The ethical dilemmas surrounding gene therapy also encompass issues of authority in deciding which human traits should be altered and concerns about discrimination against those who may not have access to or choose not to undergo gene therapy.
Revolutionary Therapies: Unleashing the Potential of Pharmaceutical Biotechnology through Recombinant Methods (Pharmaceutical Biotechnology: Therapies Developed through Recombinant Methods 2)